Feng Wang

Feng Wang is an Investigator at GlaxoSmithKline, where they provide bioanalytical support for ID CEDD. They previously worked at GSK as a Scientific Leader and DMPK Scientist in 2016, and as a Research Investigator from 2001 to 2008, focusing on structural elucidation and metabolite profiling. Prior to GSK, Feng was a Research Scientist at Gilead Sciences from 2008 to 2010, specializing in GLP bioanalytical method development and validation. They earned a PhD in Analytical Chemistry from Purdue University, where they studied from 1995 to 1999.